IPA is on a mission to redefine biotherapeutic research and technology. By integrating systems biology with LENSai technology, we enhance our advanced bioplatforms to accelerate drug discovery. Our Hub of Biotherapeutic Intelligence leads the way, offering a full continuum of customized antibody discovery and development and protein production services. Together, we support our partners in their quest to advance novel biologics against the most challenging targets.